For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
VANPPKPFEVHESGAYLHGTKAELKVGDRLVPGRESNFEAGRIMNHVYITQTLDAAVWGAELAAGEGRGR IYIVEPEGAIEDDPNVTDKKLPGNPTRSYRTREPVWIVGELTDWVGHPPEQLAAMRQGLEELRRKGLAVI YD
Operon Prediction Model: Genebank
Paralogs
species | id | gene | e-value | identity (len) | annotation |
M. smegmatis MC2 155 | MSMEG_1221 | - | - | 100% (142) | rifampin ADP-ribosyl transferase |
M. smegmatis MC2 155 | MSMEG_1224 | - | 1e-17 | 100.00% (38) | rifampin ADP-ribosyl transferase |
Closest Orthologs (e-value cutoff: 1e-4)
species | id | gene | e-value | identity (len) | annotation |
M. bovis AF2122 / 97 | - | - | - | - | - |
M. gilvum PYR-GCK | Mflv_0490 | - | 3e-62 | 78.99% (138) | hypothetical protein Mflv_0490 |
M. tuberculosis H37Rv | - | - | - | - | - |
M. leprae Br4923 | - | - | - | - | - |
M. abscessus ATCC 19977 | MAB_0591 | - | 1e-51 | 65.94% (138) | rifampin adp-ribosyl transferase |
M. marinum M | MMAR_3563 | - | 5e-63 | 80.43% (138) | rifampin ADP-ribosyl transferase |
M. avium 104 | - | - | - | - | - |
M. thermoresistible (build 8) | TH_1763 | - | 1e-34 | 76.74% (86) | rifampin ADP-ribosyl transferase |
M. ulcerans Agy99 | MUL_2796 | - | 1e-62 | 79.71% (138) | rifampin ADP-ribosyl transferase |
M. vanbaalenii PYR-1 | Mvan_0166 | - | 2e-63 | 76.76% (142) | hypothetical protein Mvan_0166 |
CLUSTAL 2.0.9 multiple sequence alignment MMAR_3563|M.marinum_M --MPAAPKPFEVHESGALLHGTKAELSVGDLLVPGRRSNYGAERLSNHVY MUL_2796|M.ulcerans_Agy99 --MPAAPKPFEVHESGALLHGTKAELSVGDLLVPGRRSNYGAERLSNHVY Mflv_0490|M.gilvum_PYR-GCK --MVQRPKPFEVHASGAYLHGTKAQLAVGDYLMPGYRSNYDDRRVMNHVY Mvan_0166|M.vanbaalenii_PYR-1 MVVPQTPKPFEVHESGAFLHGTKADLSVGDVLLPGRRSNYDEGRVMNHVY MSMEG_1221|M.smegmatis_MC2_155 --MANPPKPFEVHESGAYLHGTKAELKVGDRLVPGRESNFEAGRIMNHVY TH_1763|M.thermoresistible__bu -------------------------------------------------- MAB_0591|M.abscessus_ATCC_1997 ---MTMPNFFEAHESGAYFHGTKADLAIGDLLTPGHLSNYEEGRVMNHIY MMAR_3563|M.marinum_M VTQTLDAAVWGAELATGEGRGRIYVVEPVGALEDDPNVTDKKLPGNPTRS MUL_2796|M.ulcerans_Agy99 VTQTLDAVVWGAELATGEGRGRIYVVEPVGALEDDPNVTDKKLPGNPTRS Mflv_0490|M.gilvum_PYR-GCK ITQTLDAAVWGAELAAGEGRGRIYIVEPQGPFEDDPNVTDKKLPGNPTRS Mvan_0166|M.vanbaalenii_PYR-1 VTQTLDAAVWGAEMAAGDGRCRIFIVEPQGALEDDPNVTDKRLPGNPTRS MSMEG_1221|M.smegmatis_MC2_155 ITQTLDAAVWGAELAAGEGRGRIYIVEPEGAIEDDPNVTDKKLPGNPTRS TH_1763|M.thermoresistible__bu --------VSAAELARGDGPGRVYIVEPTGTLEDDPNVTDKKFPGNPTHS MAB_0591|M.abscessus_ATCC_1997 VTKTLVGAGLAAMMAKGEGRGHVYIVEPEGTLEDDPNVTDKKFPGNPTHS .* :* *:* ::::*** *.:*********::*****:* MMAR_3563|M.marinum_M YRTREPVRIIGELTDWAGHSPAQLQAMRDRLAQLQRQGRAVIYD MUL_2796|M.ulcerans_Agy99 YRTREPVRIIGELTDWAGHSPAQLQAMRDRLAQLQRQGRAVIYD Mflv_0490|M.gilvum_PYR-GCK FRTREPVLVVGEITDWEGHSDEQLQTMRDNLAELRRRGLDVIYD Mvan_0166|M.vanbaalenii_PYR-1 FRTREPVRIVGEITDWTGHSDEQLQAMRDSLAELRRRGLDVIYD MSMEG_1221|M.smegmatis_MC2_155 YRTREPVWIVGELTDWVGHPPEQLAAMRQGLEELRRKGLAVIYD TH_1763|M.thermoresistible__bu YRTREPVRVVGEVTDWVGHTPEQLQAMIDGLEELRRSGKAVIYD MAB_0591|M.abscessus_ATCC_1997 YRSREPVRIVGEVLDWEGPPPEFMETFRAGLADLKRKGNAVIYD :*:**** ::**: ** * . : :: * :*:* * ****